CannabisNewsBreaks

FridayMar 02, 2018 3:32 pm

CannabisNewsBreaks – Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) Pursues its Share of America’s Prosperous Cannabis Industry

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is employing a “Soil-to-Shelf” strategy for development of hemp in Canada and the United States. An article discussing the company reads: “Global Hemp plans to apply for a license to extract cannabidiol (CBD) and other cannabinoids from the upcoming industrial hemp crop in New Brunswick. Discussions are also underway with potential processing partners for the extraction of cannabinoids and straw processing for building materials from this harvest in the fall of 2018, with a longer-term plan to establish permanent processing facilities by the end of 2019. Global Hemp also continues…

Continue Reading

FridayMar 02, 2018 12:53 pm

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. Thrives in Canadian Cannabis Industry

Ultra-low cost organic cannabis producer The Green Organic Dutchman Holdings Ltd., also known as TGOD, is on track to become one of the world’s largest, most technically advanced cannabis producers. An article discussing the company reads: “Headquartered in Hamilton, Ontario, The Green Organic Dutchman Holdings Ltd., known as “TGOD”, has formed strategic alliances with industry leaders with a view to becoming the world’s largest organic cannabis company. To achieve this goal, the company has taken an approach unique in the cannabis industry, by growing cannabis organically at a low cost, expanding its cultivation facilities to scale, hiring world class senior…

Continue Reading

FridayMar 02, 2018 9:27 am

CannabisNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Receives Processing Approval from Depository Trust Company

British Columbia-based cannabis cultivation firm Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) this morning announced that it has received processing approval from The Depository Trust Company (“DTC”) of New York and, as a result, is now DTC eligible. The DTC is a subsidiary of the Depository Trust & Clearing Corporation that manages electronic clearing and settlement of publicly traded companies. Securities that are eligible to be electronically cleared and settled through DTC enjoy expedited receipt of stock and cash, which translates to an accelerated settlement process for investors. Per the update, being DTC eligible is expected to greatly simplify the…

Continue Reading

ThursdayMar 01, 2018 10:08 am

CannabisNewsBreaks – Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Subsidiary Inks Deal with Cannabis Compliance Inc.

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) president and CEO Will Rascan this morning announced that the company’s wholly-owned subsidiary, North Road Ventures, has signed an agreement with Cannabis Compliance Inc. ("CCI"). Per the terms of the agreement, CCI will be responsible for assuring the Good Manufacturing Practice (“GMP”)-compliant processing and production of North Road's products containing cannabis. GMP requirements ensure that the products manufactured are safe and of consistently high quality for their intended use. "This opens the door for North Road to obtain industry certification and regulatory authorization and/or licensing, as needed. It facilitates the…

Continue Reading

ThursdayMar 01, 2018 9:18 am

CannabisNewsBreaks – Hiku Brands Company Ltd. (CSE: HIKU) (OTC: DJACF) Subsidiary Completes Pre-Sales Inspection at West Kelowna

Canada’s first vertically-integrated cannabis brand house, Hiku Brands Company Ltd. (CSE: HIKU) (OTC: DJACF), through its DOJA Cannabis Ltd. subsidiary, this morning announced that it has completed Health Canada’s pre-sales license inspection of its West Kelowna facility. Per the update, Health Canada inspectors were onsite at the West Kelowna project throughout a three-day period ended on February 15, 2018, in an effort to verify the information submitted by DOJA as part of its application and assess the company’s compliance with applicable sections of the Access to Cannabis for Medical Purposes Regulations. This milestone is particularly noteworthy as it coincides with…

Continue Reading

WednesdayFeb 28, 2018 9:26 am

CannabisNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Adds Senior Vice President of Marketing

British Columbia-based cannabis cultivation firm Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) this morning announced its appointment of Chris Gagan to the position of Senior Vice President of Marketing in a move that’s expected to play a key role in refining the company’s brand strategy. Gagan bring more than two decades of marketing and brand development experience to Choom, having previously led the design and development team for Canada’s largest national retailer of sporting goods, FGL Sports. As Choom’s Senior Vice President of Marketing, Gagan will provide leadership and guidance related to the execution of the company’s marketing efforts, as…

Continue Reading

WednesdayFeb 28, 2018 9:25 am

CannabisNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Inks MOU with BioCan Technologies

Veritas Pharma (CSE: VRT) (OTC: VRTHF) (FRT: 2VP), a pharmaceutical and IP development firm, this morning announced that it has entered into a Memorandum of Understanding (“MOU”) with BioCan Technologies Inc. of Calgary, Alberta to collaborate exclusively to conduct additional investigations of cannabis strains being developed by Veritas’ research arm, Cannevert Therapeutics Ltd. (“CTL”). Optimizing the genetics of the cannabis plants for scientific and clinical testing over the next two years is the company’s primary focus during the collaboration. Definitive agreements relating to the MOU are anticipated to be signed by July 31, 2018. “BioCan’s geneticists will help CTL scientists…

Continue Reading

TuesdayFeb 27, 2018 3:33 pm

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) CEO, Chief Research Officer Discuss Company’s Response to Opioid Epidemic

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) was featured in an interview today by Proactive Investors. Chairman and CEO Stephen Van Deventer and chief research officer Dr. Harry Parekh discussed the company’s four programs: Sol-Gel, Nature Identical™, Dual Gene Therapy and Engineering Peptide Therapeutics. Among other topics, they discuss the rising rate of opioid overdoses and addiction, which the company’s planning to tackle utilizing its proprietary linker technology to engineer peptide therapeutics. “What's key about the technology is you cannot create tolerance to this treatment and you cannot overdose as well,” PreveCeutical chairman and CEO…

Continue Reading

TuesdayFeb 27, 2018 11:28 am

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) Completes Acquisition of ERS Holdings; Announces Private Placement of Convertible Debentures

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) this morning announced the successful completion of its acquisition of ERS Holdings, LLC (“ERS”). ERS, a privately-held California company, has developed a patented technology called Ready-To-Infuse-Cannabis (“RTIC”) which covers the transformation of cannabis oil into powder for infusion into various food and beverage products. In addition, ERS has filed several continuation patents that would permit cannabis powder to be combined with other health and wellness products such as natural sleep-aids, cold medications and vitamins. Ross Franklin, co-inventor of the patent, has been appointed as the Director of Research and Development of ERS and…

Continue Reading

TuesdayFeb 27, 2018 9:11 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Licensing Agreement with Biolog, Inc.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a biosciences company that has developed delivery technologies to improve absorption of bioactive compounds, this morning announced its entry into a definitive technology licensing agreement with Los Angeles-based, privately-held Biolog, Inc. Under the terms of this agreement, Lexaria will provide its patented DehydraTECH™ technology in an effort to empower a unique set of next-generation food and beverage cannabis infusion products to be sold in the United States. “The versatility of Lexaria's DehydraTECH™ technology is witnessed through its adoption to deliver vitamins in a nationally-available consumer product, or cannabinoids in many U.S. states,” Chris…

Continue Reading